Evidence map›Paper›PMID 39882028›Full record

ArticleInternational journal of breast cancer2025

Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention in Women at High Risk of Cancer.

Akshjot Puri, Zheng Yin, Sergio Granados-Principal, Joe Ensor, Liliana Guzman, Roberto Rosato, Hong Zhao, Stephen Wong, Lin Wang, Tejal Patel and 1 more

Abstract read
In one paragraph

Article in International journal of breast cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Akshjot PuriDepartment of Hematology and Oncology, Houston Methodist Dr Mary and Ron Neal Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0001-7187-7561
Zheng YinDepartment of Systems Medicine and Bioengineering, Houston Methodist Research Institute, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-3547-0606
Sergio Granados-PrincipalDepartment of Biochemistry and Molecular Biology 2, School of Pharmacy, University of Granada, Granada, Spain.ORCID https://orcid.org/0000-0001-8773-9489
Joe EnsorDepartment of Biostatistics, Natera Inc, Austin, Texas, USA.ORCID https://orcid.org/0000-0003-3533-4388
Liliana GuzmanHouston Methodist Research Institute, Weill Cornell Medicine, Houston, Texas, USA.
Roberto RosatoHouston Methodist Research Institute, Weill Cornell Medicine, Houston, Texas, USA.
Hong ZhaoDepartment of Systems Medicine and Bioengineering, Houston Methodist Research Institute, Houston, Texas, USA.
Stephen WongDepartment of Systems Medicine and Bioengineering, Houston Methodist Research Institute, Houston, Texas, USA.
Lin WangDepartment of Systems Medicine and Bioengineering, Houston Methodist Research Institute, Houston, Texas, USA.
Tejal PatelDepartment of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jenny C ChangDepartment of Hematology and Oncology, Houston Methodist Dr Mary and Ron Neal Cancer Center, Houston, Texas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast densityDNA damage repairhydroxytyrosololive oilWnt pathway

Identifiers

PMID39882028
PMCPMC11774573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.